China healthcare-focused, value-driven investment management group GL Capital has invested GBP9.75 million ($12.5 million) in UK-listed health technology platform Oxford BioDynamics (OBD), according to an official release.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
